| Dr Sarah Jablecki Hays, MD | |
|
One West Lakeshore Drive, Suite 220, Birmingham, AL 35209-7271 | |
| (205) 941-2020 | |
| (205) 397-4190 |
| Full Name | Dr Sarah Jablecki Hays |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | One West Lakeshore Drive, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962442707 | NPI | - | NPPES |
| 21256367107 | Other | AL | BEECHSTREET |
| P00478822 | Other | AL | RAILROAD MEDICARE |
| 08-00315 | Other | AL | SECURE HORIZIONS |
| 4090183 | Other | AL | AETNA |
| C67158 | Other | AL | VIVA |
| C67158 | Other | AL | HEALTHSPRING |
| 009912248 | Medicaid | AL | |
| 08-00315 | Other | AL | UNITED HEALTHCARE |
| 723782 | Other | AL | FIRST HEALTH |
| 51544979 | Other | BCBS | |
| C67158 | Other | AL | SENIORS FIRST |
| C67158 | Other | AL | VIVA MEDICARE |
| 051034454 | Other | AL | FEDERAL BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 00004517 (Alabama) | Primary |
| Entity Name | Visionfirst Eye Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629118286 PECOS PAC ID: 2769378777 Enrollment ID: O20040226000219 |
News Archive
Bribery in the public healthcare does not solve the problem of poor quality of services, and even exacerbates it, researchers argue.
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a report posted online today that will appear in the May print issue of Archives of Neurology, one of the JAMA/Archives journals.
Oxford Life Insurance Company today announced the release of its new Medicare Supplement product portfolio. The Phoenix-based life insurance company has plans to market Plans A, C or F, and N in more than 35 states.
Democrats on Capitol Hill hope they are nearing the finish line in their months-long quest to enact President Joe Biden's social spending agenda.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, announces the receipt of notice on June 27, 2012 from the NYSE Amex LLC, that the NYSE-Amex has accepted the CorMedix's plan to regain compliance with continued listing standards of the NYSE-Amex.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Jablecki Hays, MD 3240 Edwards Lake Parkway, Suite 100, Birmingham, AL 35235-3218 Ph: (205) 949-2020 | Dr Sarah Jablecki Hays, MD One West Lakeshore Drive, Suite 220, Birmingham, AL 35209-7271 Ph: (205) 941-2020 |
News Archive
Bribery in the public healthcare does not solve the problem of poor quality of services, and even exacerbates it, researchers argue.
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a report posted online today that will appear in the May print issue of Archives of Neurology, one of the JAMA/Archives journals.
Oxford Life Insurance Company today announced the release of its new Medicare Supplement product portfolio. The Phoenix-based life insurance company has plans to market Plans A, C or F, and N in more than 35 states.
Democrats on Capitol Hill hope they are nearing the finish line in their months-long quest to enact President Joe Biden's social spending agenda.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, announces the receipt of notice on June 27, 2012 from the NYSE Amex LLC, that the NYSE-Amex has accepted the CorMedix's plan to regain compliance with continued listing standards of the NYSE-Amex.
› Verified 3 days ago
Carol E Rosenstiel, OD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 200, Birmingham, AL 35233 Phone: 205-325-8620 | |
Alex J Wright, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1720 University Blvd, Birmingham, AL 35233 Phone: 205-325-8100 Fax: 205-325-8547 | |
Elmar M Lawaczeck, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1009 Montgomery Hwy, Suite 200, Birmingham, AL 35216 Phone: 205-397-9400 Fax: 205-397-9455 | |
Matthew Henry Oltmanns, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2208 University Blvd Ste 101, Birmingham, AL 35233 Phone: 205-933-2625 Fax: 205-558-2553 | |
Harold Augustus Helms, MD, PHD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 23rd St S, Ste 100, Birmingham, AL 35205 Phone: 205-933-2020 Fax: 205-933-0908 | |
Krupa Hasmukh Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-325-8620 | |
William Charles Gambla, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-996-8660 |